Robert Iannone
Director; EVP, Global Head of R&D & CMO · 7 filings · Latest: Aug 27, 2026
Autolus Therapeutics plc
Jazz Pharmaceuticals plc
PLIANT THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Robert Iannone | EVP, Global Head of R&D & CMO | Aug 27, 2026 | Sale | $249.70 | 76,921 | $19.2M | 65,686 | |
JAZZ | Robert Iannone | EVP, Global Head of R&D & CMO | Aug 27, 2026 | Option Exercise | $125.84 | 57,500 | $7.2M | 142,607 | |
JAZZ | ROBERT IANNONE | — | Aug 27, 2026 | Proposed Sale | $249.70 | 76,921 | $19.2M | — | |
JAZZ | ROBERT IANNONE | — | Nov 17, 2025 | Proposed Sale | $168.26 | 7,159 | $1.2M | — | |
JAZZ | Iannone Robert | — | Mar 10, 2025 | Proposed Sale | $145.00 | 1,767 | $256.2K | — | |
JAZZ | ROBERT IANNONE | — | Mar 7, 2025 | Proposed Sale | $138.73 | 5,466 | $758.3K | — | |
JAZZ | Iannone Robert | — | Mar 7, 2025 | Proposed Sale | $142.26 | 4,017 | $571.5K | — |